Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Fragile X Foundation (NFXF) is a prominent non-profit organization dedicated to supporting individuals living with Fragile X-associated disorders and their families. Founded in 1984, the foundation focuses on three core pillars: community support, government advocacy, and the advancement of scientific research. NFXF spearheads the Fragile X Clinical & Research Consortium (FXCRC), which coordinates a network of specialized clinics to standardize and improve clinical care across the United States. By funding innovative research and facilitating clinical trial recruitment, the foundation plays a vital role in accelerating the development of new therapeutic modalities, including gene therapies and small molecule interventions. It serves as a critical bridge between the patient community, academic researchers, and the pharmaceutical industry to drive progress toward effective treatments and a eventual cure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Fragile X Foundation.